Last reviewed · How we verify

NCT05506761

Rhomboid Intercostal Block Combined With Sub-Serratus Plane Block Versus Erector Spinae Plane Block

Status unknown NA Last updated 18 August 2022
What this trial tests

NA trial testing ultrasound-guided erector spinae plane block in Rib Fractures in 75 participants. Status unknown.

Timeline
1 January 2022
Primary endpoint
1 January 2023
1 January 2023

Quick facts

Lead sponsorTanta University
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment75
Start date1 January 2022
Primary completion1 January 2023
Estimated completion1 January 2023
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Tanta University

Who can join

Adults 21 to 60, any sex, with Rib Fractures. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to assess the quality of analgesic efficacy and improvement of pulmonary function in patients with fracture ribs receiving either continuous rhomboid intercostal block combined with sub-serratus block or continuous erector spinae plane block by comparing and evaluating the differences between the two techniques.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of ultrasound-guided erector spinae plane block

Trials testing the same drug.

Other recruiting trials for Rib Fractures

Currently open trials in the same condition.

Other Tanta University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05506761.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing